Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents

• Published in: PloS one 2014-06, Vol.9 (6), p.e99526-e99526
• Main Authors: Pan, Lin-na, Zhu, Wei, Li, Yang, Xu, Xu-lin, Guo, Lian-jun, Lu, Qing, Wang, Jian
• Format: Article
• Language: English
• Subjects: Activation; Adaptor Proteins, Vesicular Transport - metabolism; Analysis; Anesthesiology; Animals; Apoptosis; Astrocytes; Astrocytes - metabolism; Astrocytes - pathology; Augmentation; Biological response modifiers; Brain; Brain - pathology; Brain damage; Brain injury; Brain Ischemia - complications; Brain Ischemia - metabolism; Brain Ischemia - pathology; Brain Ischemia - prevention & control; Brain research; Cells, Cultured; Cerebral blood flow; Cerebral Cortex - metabolism; Cerebral Cortex - pathology; Cortex; Critical care; Cytokines; Damage tolerance; Deprivation; Gene expression; Glial Fibrillary Acidic Protein - metabolism; Glucose; Glucose - deficiency; Immunological tolerance; Infarction, Middle Cerebral Artery - pathology; Inflammation; Inflammatory response; Injuries; Interferon; Interferon regulatory factor; Interferon regulatory factor 3; Interferon Regulatory Factor-3 - metabolism; Interferon-beta - metabolism; Interleukin; Interleukin 6; Interleukin-6 - metabolism; Ischemia; Ischemic Preconditioning; Laboratory animals; Ligands; Male; Medicine; Medicine and Health Sciences; Mice; Neuroprotection; Neutralizing; NF-κB protein; Occlusion; Oxygen; Pharmacology; Phosphorylation; Poly (I:C); Poly I-C - pharmacology; Polyinosinic:polycytidylic acid; Preconditioning; Rats, Sprague-Dawley; Rodents; Science; Signal transduction; Signal Transduction - drug effects; Signaling; TLR3 protein; Toll-Like Receptor 3 - metabolism; Toll-like receptors; Transcription Factor RelA - metabolism; Transcription factors; Traumatic brain injury
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0099526

Cerebral ischemic preconditioning (IPC) protects brain against ischemic injury. Activation of Toll-like receptor 3 (TLR3) signaling can induce neuroprotective mediators, but whether astrocytic TLR3 signaling is involved in IPC-induced ischemic tolerance is not known. IPC was modeled in mice with three brief episodes of bilateral carotid occlusion. In vitro, IPC was modeled in astrocytes by 1-h oxygen-glucose deprivation (OGD). Injury and components of the TLR3 signaling pathway were measured after a subsequent protracted ischemic event. A neutralizing antibody against TLR3 was used to evaluate the role of TLR3 signaling in ischemic tolerance. IPC in vivo reduced brain damage from permanent middle cerebral artery occlusion in mice and increased expression of TLR3 in cortical astrocytes. IPC also reduced damage in isolated astrocytes after 12-h OGD. In astrocytes, IPC or 12-h OGD alone increased TLR3 expression, and 12-h OGD alone increased expression of phosphorylated NFκB (pNFκB). However, IPC or 12-h OGD alone did not alter the expression of Toll/interleukin receptor domain-containing adaptor-inducing IFNβ (TRIF) or phosphorylated interferon regulatory factor 3 (pIRF3). Exposure to IPC before OGD increased TRIF and pIRF3 expression but decreased pNFκB expression. Analysis of cytokines showed that 12-h OGD alone increased IFNβ and IL-6 secretion; 12-h OGD preceded by IPC further increased IFNβ secretion but decreased IL-6 secretion. Preconditioning with TLR3 ligand Poly I:C increased pIRF3 expression and protected astrocytes against ischemic injury; however, cells treated with a neutralizing antibody against TLR3 lacked the IPC- and Poly I:C-induced ischemic protection and augmentation of IFNβ. The results suggest that IPC-induced ischemic tolerance is mediated by astrocytic TLR3 signaling. This reprogramming of TLR3 signaling by IPC in astrocytes may play an important role in suppression of the post-ischemic inflammatory response and thereby protect against ischemic damage. The mechanism may be via activation of the TLR3/TRIF/IRF3 signaling pathway.